Brief: Zhongzhi Pharmaceutical Posts FY Profit Attributable RMB52.1 Million
24/03/2022 15:12
March 24 (Reuters) - Zhongzhi Pharmaceutical:
* FY PROFIT ATTRIBUTABLE RMB52.1 MILLION VERSUS RMB138.5
MILLION
* FY REVENUE RMB1.75 BILLION VERSUS RMB1.60 BILLION
Source text for Eikon: ID:nHKS6XPRVb
Further company coverage: 3737.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all newsBrief: Zhongzhi Pharmaceutical Expects Over 70% Decrease In 2025 Net Profit
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share